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Purpose: This study aimed to evaluate the effectiveness of phototherapeutic keratectomy 
(PTK) as an alternative treatment to keratoplasty using the Pentacam to assess depth of dense 
opacities.
Methodology: PTK was performed in eleven eyes of ten patients with superficial corneal 
opacities after assessment by Scheimpflug images of the Pentacam for central corneal thickness 
(CCT) and opacity level and depth.
Results: The best-corrected spectacle visual acuity (BCSVA) significantly improved. The 
preoperative mean logMAR was 0.85 (0.14 decimal equivalent, 6/42 Snellen’s equivalent), 
and the final postoperative mean logMAR was 0.58 (0.26 decimal equivalent, 6/23 Snellen’s 
equivalent). The mean preoperative CCT was 465.64 ± 71.94 µm. The mean programmed abla-
tion depth was 142.09 ± 47.58 µm. The programmed ablation depth was correlated to mean 
logMAR early (1 month) and not correlated later (6 months). None of the eyes lost lines of 
BCSVA or developed serious complications, such as keratectasia, delayed epithelialization, or 
corneal melting.
Conclusion: Corneal scars extending beyond the anterior one-fifth of the cornea can be treated 
safely and effectively by PTK due to the smoothing effect, with reduction of the cylinder rather 
than complete opacity removal. This can decrease the need for keratoplasty.
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Introduction
The 193 nm wavelength of the excimer laser has made it possible to perform 
very precise corneal surgery. The system was developed for refractive surgery 
as photorefractive keratectomy (PRK) and laser-assisted in situ keratomileusis 
(LASIK).1
Phototherapeutic keratectomy (PTK) is an important excimer laser-based surgi-
cal tool for treatment of numerous corneal disorders, such as superficial dystrophies 
and scars.2 PTK was also reported to be effective in recurrent corneal erosions,3 and 
Salzmann nodular degeneration.4 The aim of the procedure should not only be to 
increase corneal clarity but also to decrease surface irregularities, which contributes 
to improved vision. Transepithelial PTK has been described to utilize the epithelium 
as a masking agent to fill microscopic irregularities on the corneal surface.5,6
We tried to evaluate PTK after epithelial debridement as an alternative to 
  penetrating keratoplasty in the treatment of anterior corneal opacities, considering 
both opacities and irregularities.
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Methodology
Inclusion criteria
•	 Superficial corneal opacity
•	 PKP not suitable or carrying high risk
Exclusion criteria
•	 Lenticular opacity
•	 Retinal disease
•	 Glaucoma
•	 Previous laser surgery
•	 Corneal thickness , 400 um
•	 Deep corneal opacity
•	 Recurrent corneal erosions
•	 Corneal dystrophies
All cases of corneal disease that underwent PTK from 
2007 to 2011 were reviewed retrospectively from medical 
records. Details were noted regarding preoperative full 
  history and ophthalmological examination, including visual 
acuity (VA), intraocular pressure (IOP), retinal evalua-
tion, and, if possible, spherical equivalent refraction with 
best-corrected visual acuity (BCVA).
Informed consent was obtained from all patients. A detailed 
slit-lamp microscopy was performed with   particular attention 
to the corneal surface and depth of the lesion.
These parameters were assessed before examination and at 
postoperative visits. It mainly focused on laser PTK as an alterna-
tive to PKP in their superficial opacities including the possibil-
ity of need to PKP in case of unsatisfactory vision or ectasia 
development. This was especially enforced in eyes with opacities 
extending beyond anterior one fifth as case no 6 (Figures 1–4).
Preoperative assessment of central corneal thickness 
(CCT) by ultrasound was performed in all cases. A   Pentacam 
Scheimpflug examination using a WaveLight Allegro 
  Oculyzer™ (WaveLight AG, Erlangen, Germany) was also 
performed to ensure thickness assessment. In addition, a 
Pentacam examination using a density map was used to assess 
the level and depth of the opacity and to exclude lenticular 
opacity (Figures 1, 3 and 5).
As topical anesthesia, proparacaine eye drops were 
administered to all patients. The opacity diameter was 
  measured by caliber to define the treatment zone. An excimer 
laser (Allegretto; WaveLight) was used for an ablation zone 
of 5 mm to 7 mm. Q 400 was used in all eyes.
Mechanical debridement of the corneal epithelium was 
performed by dry microsponge. Resistant epithelium attach-
ment overlying some opacity was removed by a sharp Beaver 
blade.
Carboxymethyl cellulose 1% was applied as a film over 
the irregular corneal surface to avoid irregular ablation. The 
carboxymethyl cellulose film was spread by a weak jet of 
balanced salt solution (BSS; Alcon®, Fort Worth, TX) to 
make the film thinner.
Repeated ablation was performed 2 to 5 times until the 
opacity appeared less dense. One session’s ablation depth 
was 50 µm. Slit-lamp microscopy was performed whenever 
it was needed between sessions to ensure nearly complete 
removal of opacities and to avoid thinning caused by repeated 
ablations.
As a masking agent, carboxymethyl cellulose 1% was 
spread on the corneal surface before every ablation session.
It was noted that each PTK session removed part of the opac-
ity when the masking agent fluorescence began to regress.
At the conclusion of surgery, a bandage contact lens (CL) 
was applied. A postoperative slit-lamp examination was 
Figure 1 Case no 6. Preoperative Pentacam opacity measurement: segment 163°–343°.
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Figure 2 Case no 6. Postoperative Pentacam opacity: measurement segment 163°–343° with marked reduction of opacity.
performed immediately. Postoperative treatment consisted 
of ofloxacin 0.3% every 2 hours in the first 3 days, reduced 
to 6 times per day for another 3 days, and TobraDex (Alcon) 
every 12 hours until epithelium healing was complete. It then 
was increased to 6 times per day for 3 days. Ofloxacin 0.3% 
was stopped abruptly, and TobraDex was withdrawn gradu-
ally over 3 weeks. Preservative-free Refresh Plus® (Allergan, 
Irvine, CA) eye drops were used regularly every 4 hours 
for the first month, then whenever needed for the following 
3 months postoperatively. Patients were followed up at 1 day, 
3 days, 1 week, 1 month, 3 months, and 6 months.
The minimum follow-up period was 6 months, and the 
longest follow up period was 3 years. The mean follow-up 
period was 18.2 months (±6.1 months).
The main outcome measures included indications for 
the procedure, severity of postoperative pain, healing time, 
best-corrected spectacle visual acuity (BCSVA), complica-
tions, number of sessions, and ablation depth.
Statistical methods
The qualitative data are presented as numbers and percentages, 
and the quantitative data are presented as mean ± standard 
Figure 3 Case no 6. Preoperative Pentacam opacity measurement: segment 149°–329°.
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Figure 5 Case no 8. Preoperative Pentacam opacity measurement: segment 178°–353°.
deviation. The data were analyzed using a paired t-test to 
compare preoperative and postoperative parametric data, 
and a Wilcoxon test for nonparametric data. A Pearson cor-
relation coefficient was used to assess the relation between 
the study parameters. The P-value was considered signifi-
cant at ,0.05.
Results
Preoperative patient characteristics
Eleven eyes in 10 patients were operated on. The mean age 
was (42.55 years). Four eyes were in males (36.36%) and 
seven eyes were in females (63.63%). Indications for PTK in 
all eyes were superficial corneal scars of different etiologies. 
Five eyes had unknown etiology, three eyes had previous 
corneal ulcer, two eyes had corneal degeneration, and one eye 
had postsurgical scaring after pterygium surgery. The mean 
preoperative CCT was 465.64 ± 71.94 (Table 1).
Operative data
The mean programmed ablation depth was 142.09 ± 47.58, 
the mean number of ablation sessions was 2.64 ± 1.36 
(Table 2).
Figure 4 Case no 6. Postoperative Pentacam opacity measurement: segment 149°–329° with marked reduction of opacity.
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Early postoperative period
Epithelial healing was achieved after 3.55 ± 0.52 days. Maxi-
mum time for epithelial healing was 4 days. Mean duration of 
pain following the procedure was 1.55 ± 0.52 days (Table 2).
BCSVA
The mean preoperative logMAR was 0.85 ± 0.36 (0.14   decimal 
equivalent, 6/42 Snellen’s equivalent). There was significant 
improvement from baseline logMAR to postoperative logMAR 
of 0.58 ± 0.327 (0.26 decimal equivalent, 6/23 Snellen’s 
equivalent) at 1 month and 0.58 ± 0.39 at 6 months (Table 3 
and Figure 6). Improved VA was satisfactory in all patients.
There was a significant positive correlation between pro-
grammed ablation depth and postoperative mean logMAR at 
1 month (P = 0.029; r = 0.655). There was no correlation between 
programmed ablation depth and postoperative mean logMAR at 
6 months (P = 0.168; r = 0.447) (Table 4 and Figure 7). There 
was no significant relation found between preoperative CCT 
and postoperative results mean logMAR (Table 5).
At the last postoperative visit, the BCSVA was .0.5 
(6/12 Snellen’s equivalent) in three eyes (27%), 0.2–0.4 
(6/30–6/15 Snellen’s equivalent) in six eyes (55%), and 
0.05 in two eyes (18%). None of the eyes achieved 0.6–1.0 
BCSVA at the last postoperative visit. None of the eyes lost 
lines of BCSVA.
Refractive change
Changes in manifest refraction spherical equivalents 
(MRSE) were variable. The mean MRSE changed from 
−4.17 diopter (D) preoperatively to +0.75 D postopera-
tively at 6 months, which was not statistically significant 
(Table 6). Myopic shift was found in 2/11 eyes (18%) 
and hyperopic shift was found in 8/11 eyes (82%). 
There was hyperopic shift from emmetropia to +2.25 
and in case no 6 (Figures 8 and 9) and from −14.50 D 
to +2.50 D in case no 8 (Figures 10 and 11). Significant 
postoperative residual refractive error was corrected by 
contact lenses in 18% of eyes and by glasses in 82% 
of eyes.
The retrospective nature of the study did not allow post-
operative Pentacam in all cases. Postoperative Pentacam 
Scheimpflug images showed evident reduction of corneal 
opacity in case no 6 (Figures 1–4, 8 and 9) and evident 
reduction of astigmatism in case no 8 (Figures 5, 10–12).
Postoperative complications
Mild stromal haze was reported in 3/11 eyes (27%). None 
of the patients had recurrence of opacities during the 
  follow up time. None of the eyes developed keratecta-
sia, even those with long periods of follow up. Residual 
stromal opacities were noticed in 5/11 eyes (45%), which 
did not affect patient satisfaction. Improvement of VA 
was satisfactory in all patients.
Table 1 Preoperative characteristics
No Percentage
Indications 
  Unknown 
  Postulcer scar 
  Corneal degeneration 
  Postpterygium surgery
 
5 
3 
2 
1
 
45.45% 
27.27% 
18.19% 
9.09%
Central corneal thickness (µm) 
  400–500 
  500–600
 
7 
4
 
63.63% 
36.36%
Table 2 Descriptive for operative and postoperative data
Minimum Maximum Mean Standard   
deviation
Programmed ablation 
depth (µm)
70 300 142.09 74.58
Sessions 2 5 2.64 1.36
Duration of pain  
(days)
1 2 1.55 0.52
Healing time  
(days)
3 4 3.55 0.52
Table 3 Comparison between preoperative and postoperative 
mean logMAR
LogMAR Mean Standard  
deviation
t value P value
Preoperative 0.85 0.36 3.207 0.009**
Postoperative (1 month) 0.58 0.32
Preoperative visual acuity 0.85 0.36 2.318 0.043*
Postoperative (6 months) 0.58 0.39
Notes: *P , 0.05, statistically significant difference; **P , 0.01, highly statistically 
significant difference.
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Figure 6 Improvement of mean logMAR.
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Discussion
Photoablation removes corneal tissue with minimal alteration 
of adjacent corneal lamellae.1 Removal of diseased corneal 
tissue with an excimer laser used in PTK has the potential 
to improve visual function.7,8 Disorders treated with PTK 
included superficial corneal scars or irregularities, corneal 
degeneration, corneal dystrophies, and recurrent corneal 
erosions. We used the Pentacam to ensure CCT measure-
ment and opacity depth and level. Lackner et al9 stated that 
Pentacam reproducibility of CCT measurements was high-
est among ultrasound, Orbscan, and Pentacam. Similarly, 
Riss et al10 successfully used Pentacam-based deep anterior 
lamellar keratoplasty. They used Pentacam in preoperative 
pachymetry for an intended depth of trephination at 90%. 
A useful objective measurement of mild corneal haze using 
a density map was described.11
Eyes were excluded according to the following criteria: 
corneal dystrophies because of reported temporary effects 
and high recurrence rates;2,8 recurrent corneal erosion 
because of very successful outcomes both pathologically and 
visually,12 which would lead to biased outcomes if included 
together with corneas having superficial opacities; retinal or 
optic nerve disease to define visual gain; lenticular opacities 
proved by Scheimpflug Pentacam examination. Scheimpflug 
Pentacam images present an objective and repeatable method 
for assessment of cataract density, which could be helpful in 
longitudinal studies.13
We included eyes with corneal thickness of at least 
400 µm, in which PTK was a primary alternative to PKP. This 
is especially suitable for the circumstances in our country, 
which has limited availability of donor corneal tissue. This 
is supported by the proposed benefit of PTK for corneas 
with opacities extending beyond anterior one-fifth because 
entire removal of opacity is not often necessary to achieve 
visual improvement.7
Similarly, Alio et al described removal of opacities deeper 
than anterior one-fifth of the cornea.14 They removed anterior 
corneal opacities after assessment by confocal microscopy. 
They removed 335 µm opacity from 610 µm corneal thick-
ness (55% of corneal tissue), 290 µm opacity from 538 
corneal thickness (54% of corneal tissue), and 120 µm 
opacity from 408 corneal thickness (30% of corneal tissue). 
However, none of these eyes developed corneal ectasia.
Similarly, none of our eyes developed keratectasia dur-
ing the follow-up time despite having started with a mean 
CCT of 465 µm and using repeated ablation sessions. The 
explanation is that we used carboxymethyl cellulose film in 
each session, thus reducing the depth of the treatment.15 The 
result was smoothing rather than thinning of the cornea.
No correlation was found between preoperative CCT 
and postoperative mean logMAR at 1- and 6-month visits. 
Thus, PTK was equally effective in fair thickness as well 
as thin corneas. One clear consequence of this procedure is 
the induction of corneal thinning, which requires prolonged 
follow up because of its biomechanical effects.
Our patients were informed that PTK is used as an alterna-
tive to PKP with uncertain results over time. PKP is known to 
be associated with prolonged rehabilitation, risk of rejection, 
and highly irregular astigmatism.16
Scarred corneas may have different architecture and 
behavior due to changes in the collagen arrangement, which 
might be a reason for stability despite thinning. Furthermore, 
measurement of the corneal thickness may be not accurate 
in scarred cornea. This was seen in case no 8 where thinnest 
Table 5 Correlation between programmed ablation depth and   
1 month and 6 months postoperative mean logMAR
Mean logMAR Central corneal 
thickness (μm)
r P
Postoperative (1 month) 0.181 0.593
Postoperative (6 months) 0.086 0.801
Abbreviation: r, correlation coefficient.
Table 4 Correlation between programmed ablation and post-
operative mean logMAR at 1 month and 6 months
Mean logMAR Programmed ablation (μm)
r P
Postoperative (1 month) 0.655* 0.029
Postoperative (6 months) 0.447 0.168
Note: *Correlation is significant.
Abbreviation: r, correlation coefficient.
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Figure 7 Correlation between programmed ablation (µm) and postoperative mean 
logMAR at 1 month.
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Table 6 Comparison between pre and postoperative MRSE
Minimum Maximum Mean Standard deviation z P value
Preoperative refraction −16 4 −4.17 7.25 −2.136 0.065
Postoperative refraction −4.5 3.75 0.75 2.87
Abbreviations: MRSE, manifest refraction spherical equivalents; z, Wilcoxon value.
Figure 8 Case no 6. Preoperative Pentacam 4 map.
preoperative location was 429 µm. The thinnest postop-
erative location was 397 µm despite decreased opacity 
(Figures 5,10–12).
We used carboxymethyl cellulose rather than epithe-
lium as a coupling agent because scarred cornea may have 
very irregular epithelium and grossly irregular stromal 
surface.7 Therefore, we used carboxymethyl cellulose many 
times to smooth the surface before every ablation session. 
PTK improves the visual function by reducing rather than 
eliminating corneal opacity if associated with smoothing of 
the anterior corneal surface.7 This explains the significant 
improvement of BCSVA although 45% of eyes had residual 
stromal opacity. The technique of using carboxymethyl 
cellulose 1% was similarly described for elevated corneal 
opacities in corneal dystrophies as a masking agent for 
irregularities.17
An epithelial healing time of 3.55 ± 0.52 days was similar 
to van Westenbrugge’s results.18 Dogru et al15 reported 
smoothing of the corneal surface by PTK. It was also reported 
that smoothing of the corneal surface after PTK results in 
stability of the tear film and break-up time,19 which may 
improve VA. Moreover, postoperatively, a smooth surface 
avoids irregular astigmatism after lamellar corneal surgery.20 
This explained the improvement of BCSVA despite the 
incomplete opacity removal.
There was a significant correlation between programmed 
ablation depth and postoperative mean logMAR at 1 month, 
which indicated that increased ablation depth was associated 
with better logMAR. This might be because of more 
opacity removal resulting from more ablation. There was no 
correlation between ablation depth and logMAR at 6-month 
follow up, which is probably because of the epithelium 
remodeling and surface smoothing that occurred in the time 
interval. This surface smoothing resulted in compensation 
for any residual opacity effect on vision. Case no 8 showed 
reduction of astigmatism from 18.2 D to 2.6 D, which denotes 
a smoothing effect (Figures 10 and 11). However, Figures 5 
and 12 show incomplete removal of opacity.
Alio et al21 described lamellar keratectomy by auto-
mated microkeratome adjusted according to opacity depth 
  established by confocal microscope. However, they used 
sodium hyaluronate 0.25% (coupling agent) assisted PTK 
to smooth the surface.
In our study, the mean final postoperative logMAR was 
0.52 (0.3 decimal equivalent). This result differed from 
Al-Afraj et al19 and Alio et al14 who reported 0.6 decimal 
equivalent, postoperatively. This difference could be explained 
by their better starting baseline decimal equivalents, which 
was 0.4 in both studies. The starting baseline decimal equiva-
lent in our study was 0.16.
Another explanation is the inclusion criteria of Al-Afraj 
et al,19 who included eyes with recurrent corneal erosion, 
whereas the present study included only eyes with corneal 
opacities. Moreover, Alio et al14 used microkeratome automated 
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Figure 10 Case no 8. Preoperative Pentacam with preoperative astigmatism of −18.2 D.
superficial keratectomy augmented by hyaluronic acid-assisted 
PTK, which removed all opacity. The   present study removed 
less corneal tissue and therefore less opacity.
Regarding lines of improvement by decimal notation, our 
eyes improved about two lines from 0.13 to 0.2. Similarly, 
an improvement of 2 lines from 0.4 to 0.6 was found in Alio 
et al’s study.14 Another study21 reported an improvement of 
2–3 lines improvement although it used femtosecond laser-
assisted superficial lamellar keratectomy, which creates a 
more regular cut. However, hyaluronate-assisted PTK was 
used to smooth the bed further.
In our study, 27% of eyes achieved .0.5 BCSVA, 55% of 
eyes had BCSVA of 0.2–0.4, and no eyes achieved 0.6–1.0. 
These results differ from Muller et al, who reported uncorrected 
visual acuity of 0.5 or better in 70% of eyes5 and BCSVA of 
1.0 in 60% of eyes.6 The results in our study differed because 
Muller et al used a PTK–PRK mode, probably because thickness 
allowed it. Our mean CCT was 465 µm, which did not permit 
PRK–PTK. Furthermore, relatively dense opacities in our stud-
ies did not allow proper refraction to perform PRK with PTK.
Our eyes had variable postoperative MRSE, which 
could be explained by variable depths of ablation because 
of opacity depth and variable treatment zones according to 
opacity diameters.
Fagerholm20 reported that plano treatment influenced 
refraction according to depth of ablation and diameter of 
optical zone. They also reported that using a masking agent 
might alter the degree of refractive change. We used a 
Figure 9 Case no 6. Postoperative Pentacam 4 map.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
892
RashadClinical Ophthalmology 2012:6
coupling agent 2 to 5 times per case during ablation, which 
might have resulted in variable refractive change. Similar 
to our study, Al-Afraj et al19 reported variable refractive 
change with hyperopic shift in 33% of eyes and myopic 
shift in 17% of eyes. They also explained that epithelial 
remodeling and inaccuracy of preoperative refraction 
due to corneal opacification might be responsible for this 
variability.
Mild stromal haze was found in 27% of eyes in our 
study. This result differed from Al-Afraj et al,19 who 
reported mild stromal haze in 55% of eyes. This difference 
is probably because of the inclusion criteria in our study 
(corneal opacities), whereas Al-Afraj et al19 included corneal 
dystrophies characterized by recurrences.
Another explanation for less haze is that we used 
carboxymethyl cellulose to smooth the surface, which 
Figure 11 Case no 8. Postoperative Pentacam 4 map with marked reduction of astigmatism of −2.6 D.
Figure 12 Case no 8. Postoperative Pentacam opacity measurement: segment 178°–353°.
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decreases the probability of postoperative haze. On the other 
hand, Al Afraj et al19 used transepithelial PTK.
None of our patients had recurrence of opacity. This result 
differed from Hanfer et al2 who reported that 60% of their 
eyes needed keratoplasty. This difference can be explained 
by the inclusion of dystrophic corneas by Hanfer et al.
Conclusion
PTK can be considered a safe procedure with minimal side 
effects. Improvement of BCSVA can be achieved in eyes with 
anterior corneal opacities even beyond anterior one-fifth and 
in thin corneas. This result depends on smoothing the corneal 
surface instead of full elimination of opacity, which can help 
cancel or delay the need for PKP.
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